Here, we present a protocol for laparoscopic radical resection and vascular reconstruction of hilar cholangiocarcinoma with portal vein invasion, providing reproducible surgical guidance for clinical practice.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Case Report
Here, we present a protocol for laparoscopic radical resection and vascular reconstruction of hilar cholangiocarcinoma with portal vein invasion, providing reproducible surgical guidance for clinical practice.
Laparoscopic radical resection for hilar cholangiocarcinoma with vascular invasion is technically demanding but feasible in selected cases when performed by an experienced hepatobiliary surgical team. Precise minimally invasive technical execution and systematic surgical workflow organization are critical for mitigating surgical risks. We present a patient with Bismuth type IV HCCA with portal vein invasion who underwent a fully laparoscopic radical resection. The key surgical steps were as follows: (1) "en bloc" resection of hilar lymph nodes and the perihilar neural plexus; (2) segmental resection of the invaded portal vein followed by continuous suture reconstruction; and (3) microsurgical plasty of multiple bile duct orifices in conjunction with Roux-en-Y hepaticojejunostomy. The surgery was completed in 6 h, with an estimated blood loss of 200 mL and without conversion to open laparotomy. Postoperative pathological examination confirmed R0 resection with no lymph node metastases. No postoperative complications, including biliary leakage, haemorrhage, or infection, occurred. The patient remains under surveillance. Follow-up occurred at 1 month and 3 months after surgery, and subsequently occurs every 3 months. Assessments include liver function tests, tumour marker assays, and imaging (ultrasound, CT, or MRI).
Cholangiocarcinoma is a highly heterogeneous malignancy originating from the epithelial cells of the bile ducts and gallbladder1; hilar cholangiocarcinoma accounts for approximately 10%-15% of all primary liver cancers, second only to hepatocellular carcinoma2. Owing to the high degree of malignancy and strong invasiveness of this disease, despite the gradual increase in diagnostic and therapeutic regimens, the overall survival and quality of life of patients remain unsatisfactory. R0 surgical resection is widely recognized as the only potentially curative treatment modality to achieve optimal long-term survival rates3,4. Recent advancements in laparoscopic surgery have increased surgeons' confidence in managing hilar cholangiocarcinoma. Li Jun et al. reported that the application of laparoscopic techniques in the surgical treatment of perihilar cholangiocarcinoma is a safe option5,6. Studies have suggested that laparoscopic radical resection and robotic surgery are comparable to open radical resection in terms of safety and radicality, and better therapeutic effects can be achieved by selecting appropriate cases7,8,9. In experienced centres, the resectability rate is as high as 75%10. Overall, laparoscopic surgery offers several advantages, including a reduced occurrence of complications and a shorter recovery time. However, there are few reports on hilar cholangiocarcinoma with portal vein invasion, and no guidelines or consensus have been formed. In this case, the operation was completed through en bloc resection of the hilar lymph nodes and plexus, continuous suture reconstruction after resection of the invading portal vein, and microplasty of multiple bile duct openings, combined with a Roux-en-Y choledochojejunostomy, all under total laparoscopy. This case offers insights and solutions for the application of laparoscopic radical resection in patients with hilar cholangiocarcinoma and portal vein invasion.
Case presentation
A 69-year-old male was admitted to the hospital due to tea-coloured urine and a loss of appetite for more than 20 days without an obvious cause. A comprehensive abdominal ultrasound examination suggested a possible cholangiocarcinoma. He had taken self-administered medications such as Jinqiancao granules, but the symptoms did not improve significantly. He had a 15-year history of type 2 diabetes, which was controlled with metformin, dapagliflozin, and acarbose. There was no history of infectious diseases or surgeries. Physical examination revealed jaundice of the skin and sclera; no obvious tenderness, rebound tenderness, or muscular tension was found in the abdomen.
Diagnosis, assessment, and plan
Diagnostic assessment revealed elevated Carbohydrate Antigen 19-9 (CA19-9) levels at 146.5 U/mL and Carcinoembryonic Antigen (CEA) levels at 3.5 ng/mL, with liver function classified as Child-Pugh grade B. Preoperative imaging via enhanced upper abdominal computed tomography (CT) and magnetic resonance imaging (MRI) confirmed suspected hilar cholangiocarcinoma with probable vascular invasion and lymph node metastasis (Figure 1). The patient was diagnosed with hilar cholangiocarcinoma. The surgical plan comprised laparoscopic radical resection for hilar cholangiocarcinoma. This involved en bloc resection of hilar lymph nodes and the perineural plexus, followed by segmental portal vein resection with continuous suture anastomosis. The procedure concluded with microsurgical reconstruction of multiple biliary ducts and Roux-en-Y hepaticojejunostomy.
Access restricted. Please log in or start a trial to view this content.
The operation followed standard procedures and received ethics approval. This study was approved by the Ethics Committee of the First Affiliated Hospital of Chongqing Medical University. Informed written consent was obtained from the patient. The reagents and the equipment used are listed in the Table of Materials.
1. Preoperative preparation
2. Surgical procedure
Access restricted. Please log in or start a trial to view this content.
In this case report, total laparoscopic radical resection was successfully performed for Bismuth type IV hilar cholangiocarcinoma with portal vein invasion. Postoperative pathology confirmed R0 resection. The operation duration was 6 h, with 200 mL of intraoperative blood loss and without conversion to laparotomy (Table 1). Upon discharge, a re-examination of liver function revealed that the total bilirubin level was less than 30 µmol/L and the ALT level was less than 50 ...
Access restricted. Please log in or start a trial to view this content.
HCCA is a prevalent malignancy of the biliary tract, constituting approximately 50% of all biliary tract malignancies11. Radical resection remains the sole potentially curative therapeutic modality. While traditional open surgery facilitates R0 resection under direct visualization, it necessitates a large incision, entails a prolonged recovery period, and is associated with a relatively high risk of multiple complications, consequently leading to extended hospital stays12
Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| Ablation electrode (multifunctional surgical dissector) | Nanchang Huaan Company | B1 | Sterile, ethylene oxide sterilized, disposable |
| Alligaclip Absorbable Ligating Clip | Covidien | 8886848813 | Sterile, ethylene oxide sterilized, disposable |
| Barbed suture | Covidien | 3-0/4-0 | Sterile, ethylene oxide sterilized, disposable |
| Disposable non-absorbable ligating clips | Beijing Bohui Company | RJLK-S/RJLK-M | Sterile, ethylene oxide sterilized, disposable |
| Disposable staple cartridge 60 | Tianjin Ruiqi Company | SRC60 | Sterile, ethylene oxide sterilized, disposable |
| Electric laparoscopic linear cutting stapler and staple cartridge | Johnson (USA) | PSEE60A | Sterile, ethylene oxide sterilized, disposable |
| Trocar | Surgaid Medical?Xiamen?Co., Ltd | NPCM-100-12;NPVM-100-3-C | Sterile, ethylene oxide sterilized, disposable |
Access restricted. Please log in or start a trial to view this content.